Supramolecular nanofibers co-loaded with dabrafenib and doxorubicin for targeted and synergistic therapy of differentiated thyroid carcinoma

Rationale: Although surgery, radioiodine therapy, and thyroid hormone therapy are the primary clinical treatments for differentiated thyroid carcinoma (DTC), effective therapy for locally advanced or progressive DTC remains challenging. BRAF V600E, the most common BRAF mutation subtype, is highly re...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Peng, Cai, Xiaoyao, Mu, Ganen, Duan, Yuansheng, Jing, Chao, Yang, Zhimou, Yang, Cuihong, Wang, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157742/
https://www.ncbi.nlm.nih.gov/pubmed/37153748
http://dx.doi.org/10.7150/thno.82140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157742/
https://www.ncbi.nlm.nih.gov/pubmed/37153748
http://dx.doi.org/10.7150/thno.82140

Ejemplares similares